Industry: Pharmaceuticals (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-03-17 | New | $12,499,825 | $12,499,825 | Equity Only | 06b | SEC link |
Name | Role |
---|---|
George Anastassov | Director |
Luigi M. Barbato | Executive |
Lekhram Changoer | Executive |
Robert Clark | Director |
Joel Latham | Director, Executive |
Joseph Swan | Executive |
Troy Valentine | Director |
Peter Widdows | Director |